- Home
- OGEN vs MITQ Comparison
OGEN vs MITQ Comparison
Compare OGEN & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- MITQ
- Stock Information
- Founded
- OGEN 1996
- MITQ N/A
- Country
- OGEN United States
- MITQ United States
- Employees
- OGEN N/A
- MITQ N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- MITQ Telecommunications Equipment
- Sector
- OGEN Health Care
- MITQ Telecommunications
- Exchange
- OGEN Nasdaq
- MITQ Nasdaq
- Market Cap
- OGEN 4.6M
- MITQ 5.5M
- IPO Year
- OGEN N/A
- MITQ 2021
- Fundamental
- Price
- OGEN $4.13
- MITQ $0.65
- Analyst Decision
- OGEN
- MITQ
- Analyst Count
- OGEN 0
- MITQ 0
- Target Price
- OGEN N/A
- MITQ N/A
- AVG Volume (30 Days)
- OGEN 656.3K
- MITQ 9.7M
- Earning Date
- OGEN 08-08-2025
- MITQ 05-15-2025
- Dividend Yield
- OGEN N/A
- MITQ N/A
- EPS Growth
- OGEN N/A
- MITQ N/A
- EPS
- OGEN N/A
- MITQ N/A
- Revenue
- OGEN N/A
- MITQ $18,613,000.00
- Revenue This Year
- OGEN N/A
- MITQ N/A
- Revenue Next Year
- OGEN N/A
- MITQ N/A
- P/E Ratio
- OGEN N/A
- MITQ N/A
- Revenue Growth
- OGEN N/A
- MITQ N/A
- 52 Week Low
- OGEN $3.12
- MITQ $0.50
- 52 Week High
- OGEN $75.60
- MITQ $1.55
- Technical
- Relative Strength Index (RSI)
- OGEN 47.04
- MITQ 57.86
- Support Level
- OGEN $3.41
- MITQ $0.61
- Resistance Level
- OGEN $4.85
- MITQ $1.10
- Average True Range (ATR)
- OGEN 0.58
- MITQ 0.06
- MACD
- OGEN 0.01
- MITQ 0.01
- Stochastic Oscillator
- OGEN 42.49
- MITQ 29.49
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.